DK1135154T3 - Forbedring af follikulogenese - Google Patents
Forbedring af follikulogeneseInfo
- Publication number
- DK1135154T3 DK1135154T3 DK99961017T DK99961017T DK1135154T3 DK 1135154 T3 DK1135154 T3 DK 1135154T3 DK 99961017 T DK99961017 T DK 99961017T DK 99961017 T DK99961017 T DK 99961017T DK 1135154 T3 DK1135154 T3 DK 1135154T3
- Authority
- DK
- Denmark
- Prior art keywords
- gdf
- folliculogenesis
- improvement
- gonadotropins
- maturation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0608—Germ cells
- C12N5/0609—Oocytes, oogonia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/19—Growth and differentiation factors [GDF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/31—Pituitary sex hormones, e.g. follicle-stimulating hormone [FSH], luteinising hormone [LH]; Chorionic gonadotropins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2517/00—Cells related to new breeds of animals
- C12N2517/10—Conditioning of cells for in vitro fecondation or nuclear transfer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Developmental Biology & Embryology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98204048 | 1998-12-01 | ||
PCT/EP1999/009210 WO2000032222A1 (en) | 1998-12-01 | 1999-11-25 | Improvement of folliculogenesis |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1135154T3 true DK1135154T3 (da) | 2003-08-11 |
Family
ID=8234412
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99961017T DK1135154T3 (da) | 1998-12-01 | 1999-11-25 | Forbedring af follikulogenese |
Country Status (11)
Country | Link |
---|---|
US (1) | US6660717B1 (da) |
EP (1) | EP1135154B1 (da) |
JP (1) | JP2002531414A (da) |
AT (1) | ATE239495T1 (da) |
AU (1) | AU770933B2 (da) |
CA (1) | CA2353085A1 (da) |
DE (1) | DE69907725T2 (da) |
DK (1) | DK1135154T3 (da) |
ES (1) | ES2200579T3 (da) |
PT (1) | PT1135154E (da) |
WO (1) | WO2000032222A1 (da) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1176976B2 (en) * | 1999-05-07 | 2015-10-21 | Laboratoires Serono SA | Use of lh administered in mid- or late-follicular phase for the treatment of anovulatory women |
NZ502796A (en) * | 2000-06-15 | 2003-02-28 | Agres Ltd | Nucleotide and amino acid sequences of oocyte factors related to GDF-9B or GDF-9 |
CA2615006A1 (en) * | 2005-07-18 | 2007-01-25 | Adelaide Research And Innovation Pty Ltd | Modulation of granulosa cell apoptosis |
CA2894479A1 (en) | 2011-12-14 | 2013-06-20 | The Board Of Trustees Of The Leland Stanford Junior University | Stimulation of ovarian follicle development and oocyte maturation |
CN112010271B (zh) * | 2020-09-28 | 2022-03-25 | 江南大学 | 一种球形硒纳米颗粒及其制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4196123A (en) * | 1978-11-20 | 1980-04-01 | Eugenia Rosemberg | Hybrid chorionic gonadotropin preparations and methods for stimulating ovulation using same |
US4725579A (en) * | 1985-02-21 | 1988-02-16 | Serono Laboratories, Inc. | Method of in vitro fertilization by a unique combination of gonadotropins |
US5821056A (en) * | 1993-01-12 | 1998-10-13 | The Johns Hopkins University School Of Medicine | Growth differentiation factor-9 |
CA2153653C (en) | 1993-01-12 | 2010-12-07 | Se-Jin Lee | Growth differentiation factor-9 |
CA2181711A1 (en) | 1994-01-20 | 1995-07-27 | Renato De Leeuw | New composition of glycoprotein isoforms having follicle stimulating activity |
WO1997031020A1 (en) | 1996-02-22 | 1997-08-28 | The General Hospital Corporation | METHODS AND COMPOSITIONS FOR ENHANCING CELLULAR RESPONSE TO TGF-β LIGANDS |
DE69814352T3 (de) | 1997-02-07 | 2009-08-13 | Stryker Corp., Kalamazoo | Matrixlose osteogene vorrichtungen und implantate und verfahren zu deren verwendung |
-
1999
- 1999-11-25 ES ES99961017T patent/ES2200579T3/es not_active Expired - Lifetime
- 1999-11-25 WO PCT/EP1999/009210 patent/WO2000032222A1/en active IP Right Grant
- 1999-11-25 PT PT99961017T patent/PT1135154E/pt unknown
- 1999-11-25 CA CA002353085A patent/CA2353085A1/en not_active Abandoned
- 1999-11-25 DE DE69907725T patent/DE69907725T2/de not_active Expired - Lifetime
- 1999-11-25 DK DK99961017T patent/DK1135154T3/da active
- 1999-11-25 US US09/856,995 patent/US6660717B1/en not_active Expired - Fee Related
- 1999-11-25 AT AT99961017T patent/ATE239495T1/de not_active IP Right Cessation
- 1999-11-25 EP EP99961017A patent/EP1135154B1/en not_active Expired - Lifetime
- 1999-11-25 JP JP2000584913A patent/JP2002531414A/ja active Pending
- 1999-11-25 AU AU17778/00A patent/AU770933B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
AU1777800A (en) | 2000-06-19 |
CA2353085A1 (en) | 2000-06-08 |
DE69907725T2 (de) | 2004-03-18 |
JP2002531414A (ja) | 2002-09-24 |
DE69907725D1 (de) | 2003-06-12 |
ES2200579T3 (es) | 2004-03-01 |
PT1135154E (pt) | 2003-08-29 |
ATE239495T1 (de) | 2003-05-15 |
US6660717B1 (en) | 2003-12-09 |
EP1135154B1 (en) | 2003-05-07 |
AU770933B2 (en) | 2004-03-11 |
EP1135154A1 (en) | 2001-09-26 |
WO2000032222A1 (en) | 2000-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GT199800197AA (es) | Proceso para la sintesis de 1,3-dioles | |
NO993053L (no) | Blanding for å farge keratinfibre og fargemetode for anvendelse derav | |
DE69726714T2 (de) | 9-oximsilyl erythromycin a derivate | |
TR200602095T2 (tr) | Hümanize Anti-LT-Beta-R antikorları | |
ATE397488T1 (de) | Vorrichtung zur herstellung von liposomen | |
EA199700170A1 (ru) | Способ получения некоторых азациклогексапетидов | |
ID26992A (id) | Kantong berisi pengharum yang lepas lama metode penggunaannya dan metode pembuatannya | |
AU3327795A (en) | Natriuretic cyclic compounds | |
KR970704430A (ko) | 전립선 질환, 자궁내막증 및 비만증의 치료를 위한 드롤록시펜의 용도(use of droloxifene for the treatment of prostatic diseases endometriosis and obesity) | |
DK0880350T3 (da) | Behandling af dissemineret sklerose | |
DK1032378T3 (da) | Anvendelse af en blanding af en diol og en alfa-hydroxysyre til behandling af hyperkeratosiske hudsygdomme | |
DK1135154T3 (da) | Forbedring af follikulogenese | |
EE200200337A (et) | Uued ühendid ning nende kasutamine | |
PT99894A (pt) | Processo para a preparacao de compostos 2-aril-5-(trifluorometil)-2-pirroles insecticidas | |
PL315777A1 (en) | Novel analgesic and locally anaesthetising agents | |
DE69533311D1 (de) | Verfahren zur behandlung von autoimmunerkrankungen mittels typ-1-interferonen | |
AU736977C (en) | Peptide-based immunotherapeutic agent | |
MY133881A (en) | "calcilytic compounds" | |
BR0012006A (pt) | Método para evitar inflamações, doenças autoimunes e crescimento de tumor, e, uso de substâncias que suprimem a ativação mediada por ltbr | |
BR9510198A (pt) | Composto azo pirazolona processo para a sua preparação e utilização do composto | |
DE69721831D1 (de) | Aphrodisiakum zur anwendung an den geschlechtsorganen | |
ATE270113T1 (de) | Zusammenstellungen zur verbesserten wundheilung | |
AU4193800A (en) | Use of tagatose to enhance key blood factors | |
DK0697854T3 (da) | Anvendelse af hydroxynapthalener i farvemidler. | |
HN1998000013A (es) | Metodo para la preparacion de (is,4q)-1-azabiciclo (2.2.1) heptano 3-uno y (1r,45), 1-azabiciclo (2.2.1) heptano 3-uno. |